Prestige Consumer Healthcare Inc (PBH)
84.14
+1.47
(+1.78%)
USD |
NYSE |
Nov 21, 16:00
84.19
+0.05
(+0.06%)
After-Hours: 20:00
Prestige Consumer Healthcare Profit Margin (Quarterly): 19.16% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 19.16% |
June 30, 2024 | 18.37% |
March 31, 2024 | 17.86% |
December 31, 2023 | 18.76% |
September 30, 2023 | 18.71% |
June 30, 2023 | 19.07% |
March 31, 2023 | -84.15% |
December 31, 2022 | 18.86% |
September 30, 2022 | 17.64% |
June 30, 2022 | 19.95% |
March 31, 2022 | 19.51% |
December 31, 2021 | 18.30% |
September 30, 2021 | 16.41% |
June 30, 2021 | 21.46% |
March 31, 2021 | 14.94% |
December 31, 2020 | 17.12% |
September 30, 2020 | 18.78% |
June 30, 2020 | 19.05% |
March 31, 2020 | 14.75% |
December 31, 2019 | 15.76% |
September 30, 2019 | 13.97% |
June 30, 2019 | 14.61% |
March 31, 2019 | -57.78% |
December 31, 2018 | 15.81% |
September 30, 2018 | 12.88% |
Date | Value |
---|---|
June 30, 2018 | 13.57% |
March 31, 2018 | -15.50% |
December 31, 2017 | |
September 30, 2017 | 11.90% |
June 30, 2017 | 13.16% |
March 31, 2017 | 4.61% |
December 31, 2016 | 14.60% |
September 30, 2016 | 14.97% |
June 30, 2016 | -2.64% |
March 31, 2016 | 6.70% |
December 31, 2015 | 13.98% |
September 30, 2015 | 15.43% |
June 30, 2015 | 13.62% |
March 31, 2015 | 12.51% |
December 31, 2014 | 10.78% |
September 30, 2014 | 9.08% |
June 30, 2014 | 11.48% |
March 31, 2014 | 11.19% |
December 31, 2013 | 2.16% |
September 30, 2013 | 19.64% |
June 30, 2013 | 14.52% |
March 31, 2013 | 12.81% |
December 31, 2012 | 7.65% |
September 30, 2012 | 11.89% |
June 30, 2012 | 9.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-84.15%
Minimum
Mar 2023
21.46%
Maximum
Jun 2021
13.01%
Average
18.54%
Median
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -49.65% |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 12.55% |
Return on Assets | 6.20% |
Return on Invested Capital | 7.39% |
Gross Profit Margin (Quarterly) | 55.46% |
Operating Margin (Quarterly) | 29.72% |
Return on Net Operating Assets | 6.32% |